Neuralink, Elon Musk’s brain-computer interface startup, has been making significant strides since launching human clinical trials in 2024. Here's the latest and greatest from PRIME, Telepathy, and their futuristic Blindsight vision system:

#Highlights & Routes Forward

1. Human Trial Expansion & Milestones

• In early 2024, the first human patient (Noland Arbaugh) received the N1 “Telepathy” implant, enabling control of a cursor via thought. Despite ~85% thread detachment, software updates helped Noland regain substantial functionality
  CTOL Digital Solutions, The Guardian

• The second patient ("Alex") received the implant in mid‑2024, demonstrated record-setting cursor control, used CAD tools, and played FPS games using mental control—with no thread retraction observed
  teslanorth

• A fifth patient (RJ, a paralyzed veteran) was implanted in April 2025 at the University of Miami and now controls devices—including TV and smartphone—using Neuralink with remarkable success. New York Post

2. FDA Breakthrough Designations & Funding Windfall

• Neuralink received Breakthrough Device status from the FDA for both its speech-restoration and vision-restoration (Blindsight) systems—this designation speeds regulatory review and access to patients in need.
• In June 2025 it secured $650 million in funding, doubling down on its $9 billion valuation and enabling expansion of trials into three countries, targeting powerful therapeutic applications for paralysis, vision, and speech restoration.
  Reuters

3. Blindsight: Vision Restoration & Superhuman Senses

• Neuralink’s experimental Blindsight implant, tested in monkeys, has successfully stimulated the visual cortex—prompting subjects to respond to nonexistent visual cues about two-thirds of the time.
• Elon Musk has publicly indicated that support for hearing restoration is next, citing a “clear path” toward helping even congenitally deaf individuals by directly activating sound-processing neurons.
  India Times

4. Technology Upgrades & Robotic Scaling

• Neuralink's second-generation chip and surgical robot feature more electrodes, higher bandwidth, longer battery life, and improved reliability—with 3D electrode arrays in the works to enhance spatial targeting.
• The company is collaborating with Tesla to enable robotic hand control via neural implants—users like “Alex” have already operated a Tesla Optimus robot and a robotic arm in demos.

#What to Keep an Eye On Next

• FDA-cleared human Blindsight trials for vision restoration
• Neuralink’s speech-restoration system prototyping
• New peer-reviewed research on safety and long-term usage, especially regarding thread retention
• Wider trial enrollment expansion in 2025 (targeting 20–30 participants and hundreds by 2026)

Neuralink is evolving from feasibility-studies into real-life applications for severe paralysis, communication impairments, and sensory restoration—with regulatory green lights and increasing technical sophistication accelerating the pace. Thoughts on where neural interfaces go from here?